对儿童对非类固醇抗炎药物 (NSAIDs) 过敏的实践方法
Daniela Podlecka1, Anna Socha-Banasiak2, Joanna Jerzynska1
1Department of Pediatrics and Allergy, Copernicus Memorial Hospital in Lodz, Medical University of Lodz, 90-419 Lodz, Poland.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2023
概括
非类固醇抗炎药物 (NSAID) 过敏影响30.1%的儿童出现不良反应. 易布洛芬引起的过敏通常会导致疹和血管,而维生素D缺乏是危险因素.
科学领域:
- 儿科过敏和免疫学
- 药物监督 药物监督 药物监督
- 临床诊断 临床诊断 临床诊断
背景情况:
- 评估儿童对NSAIDs药物过敏的现实世界流行情况.
- 描述病人的个人资料和不良事件后的临床表现.
- 使用药物挑战测试进行验证.
研究的目的:
- 为了确定NSAID过敏症在儿童中的患病率.
- 为了确定患者的人口统计和NSAID过敏的临床症状.
- 探索与NSAID过敏相关的危险因素.
主要方法:
- 包括56名儿童 (4至18岁) 涉嫌对NSAIDs产生不良反应.
- 皮肤刺伤试验和药物诱导试验的执行.
- 持续性疹症的诊断工作.
主要成果:
- 在30.1%的患者中证实了NSAID过敏 (17/56).
- 血管和疹是最常见的表现 (84.9%).
- 布洛芬是最常见的NSAID;维生素D缺乏是显著的危险因素 (OR=5.76).
结论:
- 在小儿过敏中,NSAID过敏会带来诊断挑战.
- 急性疹和血管是儿童易布洛芬过敏的关键指标.
- 维生素D水平和病毒感染需要进一步研究作为潜在的辅助因子.
相关概念视频
Hypersensitivities
718
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
718
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Peptic Ulcer Disease IV: Management
109
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
109
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
503
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
503
Therapeutic Index
4.3K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.3K
Allergic Reactions
27.7K
Overview
27.7K


